Download presentation
Presentation is loading. Please wait.
Published byMagdalene Norton Modified over 9 years ago
1
STDs/STIs M. Kent Froberg, MD 2009
2
Purpose Learn for the most common/important STIs: The classification and characteristics of each etiologic agent, epidemiology, prevalence, spectrum of clinical disease, diagnosis, pathology, treatment (pharmacology lectures) and prevention.
3
Organisms 1. Viruses 1.Herpes simplex viruses: HSV-1 & HSV-2 2.Human papilloma viruses: HPV 3.Human Immunodeficiency Virus: HIV (covered elsewhere) 4.Hepatitis B Virus: HBV (covered elsewhere)
4
Organisms 2. Protozoa 1.Trichomonas vaginalis
5
Organisms 3. Bacteria 1.Chlamydia trachomatis 2.Neisseria gonorrhoeae 3.Treponema pallidum 4.Haemophilus ducreyi
6
Important Concepts Many STIs asymptomatic/subclinical Are 5 of the 10 most common infections reported by CDC Rates of STIs probably underestimated Concurrent infections common Nearly all STIs risk of HIV infection
7
More Concepts > 15 million STIs per year in US Rates in US double those of England, Canada, Germany, Sweden While syphilis & gonorrhea have declined recently, chlamydia, HPV & HSV have all Physicians may not include an adequate sexual Hx and genital exam as part of routine H & P www.cdc.gov/std/
8
Frequency/Impact HPV: ~ 20 million infected in US, 5.5 million new infections per year HSV-2: ~ 45 million infected in US Chlamydia*: > 3 million new infections per year in US Trichomoniasis: ~ 5.5 million infected Gonorrhea*: ~ 360,000 cases reported in 2001 Syphilis*: ~ 6,000 cases reported in 2001, 440 congenital * Reportable in Minnesota
9
HSV 1 & 2 Enveloped DNA viruses causing cold sores & genital herpes Genital herpes mostly HSV-2, but HSV-1 increasing (up to 40% in some populations) Facial herpes mostly HSV-1 (5% HSV-2) Antibodies to one somewhat inhibitory to the other Genomes show 50-70% homology between HSV- 1 & HSV-2 Man only natural host
10
Clinical Disease Localized vs disseminated ( in immunosuppressed) 1. Herpes Labialis : cold sores 2.Ocular Herpes: keratoconjunctivitis 3. Herpes Genitalis 4. Cutaneous lesions: herpetic whitlow 5. Meningitis 6. Encephalitis: temporal lobe 7. Neonatal herpes
11
Herpesvirus Particle HSV-2 virus particle. Note that all herpesviruses have identical morphology and cannot be distinguished from each other by electron microscopy.
12
Herpes HSV is spread by contact, virus is shed in saliva, tears, genital and other secretions. Most common form of infection results from a kiss given to a child or adult from a person shedding the virus. HSV-1 1 infection is usually trivial or subclinical in most individuals. There are 2 peaks of incidence, the first at 0 - 5 years and the second in the late teens, when sexual activity commences. About 10% of the population acquires HSV infection through the genital route and the risk is concentrated in young adulthood.
13
Herpes Pathology Latency in craniospinal ganglia Reactivation: 45% for facial, 60% for genital More likely if immunosuppressed Triggers: stress, menstruation, infection, fever Genital recurrence: 1.6 episodes/yr, with time Asymptomatic shedding highest in 1st six months following 1 infection
14
Genital herpes — Initial visits to physicians’ offices: United States, 1966–2002
15
Herpes simplex virus type 2 infections — Percent seroprevalence according to age in NHANES II (1976-1980) and NHANES III (1988-1994)
16
Genital Herpes Causes latent & recurrent infections Transmission: direct contact (genital/genital or oral/genital) Most transmission when there are no active lesions – important for pts to know/understand 1 infection often more severe than recurrences 60% of pts have recurrent disease
17
Genital Herpes Pathology Infection by direct contact with mucocutaneous tissue breaks Prodrome of tingling, burning, pain Papule vesicle (clear fluid filled) ulcer Intra-nuclear inclusions (Cowdry A & B), multinucleated giant cells at base of vesicle Ulcer 2 infection (Staph, Strep, Candida)
18
Neonatal Herpes HSV spread to neonate during vaginal delivery (doesn’t cross placenta) Mostly from asymptomatic mothers Incidence: 1/4000 LBs in US Transmission more common with 1 vs recurrent infection (33 vs 3% in one series) Earlier gestational delivery risk Caesarian section risk
19
Neonatal Herpes 80% due to HSV-2 50% mortality CS x within first 10 days of life Pathology: foci of necrosis in multiple organs (liver, adrenal, lung, brain) Long-term CNS deficits/blindness in 25- 30%
20
Early papules & vesicles of genital herpes
21
Confluent vesicles of Herpes
22
Polykaryon from HSV-2
23
Multiple papules of Herpes
24
Subcorneal vesicle of HSV-1
25
Polykaryons with intranuclear inclusions at base of vesicle
26
Crusted ulcers from facial herpes
27
Papules & confluent vesicles of HSV
28
Dewdrop-like vesicles of genital herpes
29
Cowdry A inclusions of HSV
30
Fatal hepatitis from HSV-1 in immunocompromised patient
31
Geographic necrosis from fulminant HSV hepatitis
32
Intranuclear inclusions within hepatocytes
33
HSV-1 encephalitis with focal necrosis of temporal lobe
34
HSV encephalitis destroying unilateral inferior temporal lobe
35
Laboratory Diagnosis Virus Isolation –HSV-1 and HSV-2 are among the easiest viruses to cultivate. It usually takes only 1 - 5 days for a result to be available. Is gold standard. Direct Detection –Tzanck smear of vesicle base –Immunofluorescence of skin scrapings - can distinguish between HSV and VZV –PCR - now used routinely for the diagnosis of herpes simplex encephalitis Serology –Not that clinically useful.
36
Cell Culture Cytopathic Effect of HSV in cell culture: Note the ballooning of cells.
38
Herpes Treatment Antiviral chemotherapy indicated where the primary infection is especially severe, dissemination, sight is threatened, and herpes simplex encephalitis. Acyclovir – this is the drug of choice for most situations. I.V. (HSV infection in normal and immunocompromised patients) Oral (treatment and long term suppression of mucocutaneous herpes and prophylaxis of HSV in immunocompromised patients) Cream (HSV infection of the skin and mucous membranes) Ophthalmic ointment Famciclovir and valacyclovir – oral only, more expensive than acyclovir.
39
Acyclovir Converted to acyclovir monophosphate by viral thymidine kinase Then to acyclovir triphosphate by cellular kinases inhibits viral DNA polymerase early termination of viral DNA ~1% of HSV lack thymidine kinase resistant to acyclovir
40
Human Papilloma Virus Naked dsDNA virus of papovavirus family Produce latent & chronic infections HPV replicates in epithelial cells of skin, vagina, cervix, larynx, etc. Transmitted by direct contact Tumorogenic: causes warts, anogenital condylomas and dysplasia
41
HPV 60-100 different types described, 30-40 infect human genitalia Classified by genotyping Small virus (55 nm), circular DNA with 10 ORFs (E1-8, L1 & L2) New type defined as having < 50% homology with known HPV types
42
Clinical Disease Common warts: verruca vulgaris Most common types: 1, 2, 4 Predilection for keratinized epithelium/do not cause genital lesions (except HPV 2) Laryngeal warts: HPV 11 (~congenital)
43
Tumorogenic Types Anogenital warts (condyloma accuminatum): HPV 6, 10, 11, 40-45 (episomal viral DNA) Types 6 & 11 ~ 70% Cervical cancer: HPV 16, 18, 33, 45, 46 70% HPV 16 or 18 (integrated viral DNA) HPV 16 most common type (50%) overall HPV genomes found in >95% of all cervical cancer specimens (squamous cell & adenocarcinomas) 270,000 deaths from cervical cancer worldwide
44
Pathology Infected epithelial cells koilocytes Koilocytes: cells with nuclear size, N/C, irregular nuclear contours (raisinoid), nuclear hyperchromasia, perinuclear halo Can transform cells in culture E6 binds p53 (early degradation blocks apoptosis) E7 binds Rb gene (unrestrained cell proliferation)
45
E7 from HPV replaces E2F at binding site with pRb. This allows transcriptional activation and cell proliferation.
46
Epidemiology Incidence and prevalence unknown 65% of sexual contacts of partners with condylomas displayed genital warts within 6 weeks Multiple HPV types in ~ 25% of infections Most infections spontaneously regress within 2 yrs Most common in young adults, decline with age Only a small minority of women with HPV DNA by molecular techniques have gross or microscopic abnormalities HPV infection 4x if HIV +
47
HPV Pathology & Rx: refer to lecture on cervix HPV 16 vaccine clinical trials: Females age 16-23 got HPV-16 virus- like-particle vaccine (x3) or placebo, followed and tested for HPV-16 infection for ~17 months 768 got vaccine with 0 HPV-16 infections 765 got placebo with 41 HPV-16 (3.8%/100 women-years) infections (NEJM 2002;347:1645- 51)
48
Vaccine Gardasil recombinant virus-like particles (VLPs) from L1 protein (major capsid protein) –Lack viral DNA – reasure pts they can’t get virus from vaccine –Prevents infection from types 6, 11, 16 & 18 –6 & 11 cause ~90% of genital warts –FDA approved June 2006
49
Condyloma accuminatum
51
Koilocyte with nuclear enlargement, hyperchromasia, N/C ratio, irregular nuclear contour & perinuclear halo
52
Trichomonas vaginalis Ubiquitous flagellated protozoan, most common non-viral STD per WHO Lives in lumen of vagina, urethra, prostatic ducts, under foreskin of uncircumcised males Does not invade tissues 170 million cases worldwide Causes trichomoniasis Humans only natural host
53
T. vaginalis Fastidious, anaerobe Iron from menses may facilitate overgrowth Not reportable in US (~3-6 million new cases/yr) Prevalence in STD clinics may approach 40% Much less frequent in men (~5% of urethritis) Peak incidence 16-35 yrs of age risk if African-American, multiple sexual partners
54
Trichomoniasis and other vaginal infections — Initial visits to physicians’ offices: United States, 1966–2002
55
Trichomoniasis Transmission via sexual intercourse Rate of infectivity estimated at 70-80% Rates higher from men to women than women to men Incubation period 4-28 days Not spread by fomites
56
Clinical Disease Acute or chronic vaginitis Yellow-green, frothy or bubbly, purulent discharge, pruritis and dysuria Discharge in < 50% of women Exacerbated by menses (pH 5-5.5) Urethritis more common in men White, milky urethral discharge
57
Pathology Gross: discharge, multiple, punctate hemorrhages and/or areas of capillary dilitation on cervix (“strawberry cervix”) Organism may adhere to squamous epithelium Acute inflammation
58
Diagnosis & Treatment Wet mount of scrapings of vaginal fornices Can see motile organisms under phase contrast microscope Others: Giemsa stain of scrapings, PAP smear, ELISA on vaginal secretions Rx: metronidazole 82-100% cure rates Should Rx sexual partners
59
Chlamydia trachomatis Small Gram negative bacterium Obligate intracellular pathogens Biphasic developmental cycle Infectious form is elementary body (EB) 0.3-0.4 m EB is metabolically inert EB taken up by epithelial cells reticulate body (RB)
60
Chlamydia trachomatis RB metabolically active Utilizes host cell ATP for energy Multiples by binary fission within endosome (inclusion body with 100-500 progeny) Result host cell ruptures or expels inclusion body Infect columnar epithelium Chlamydia inhibit fusion of endosome with lysosomes (resist intracellular killing)
61
C. trachomatis Multiple biovars D-K cause nongonococcal urethritis in men; urethritis, cervicitis, salpingitis and pelvic inflammatory disease (PID) in women Can cause inclusion conjunctivitis in neonates L1-3 cause lymphogranuloma venereum (LGV rare in US- <600/yr)
62
Epidemiology Most common bacterial STD in developed world Rate in STD clinics 15-19% Leading cause of ectopic pregnancy (secondary to PID b/c inflammation and scarring of fallopian tubes) Risk factors: < 25 yrs, African-American race, multiple sexual partners. Concurrent infection with GC Majority of infections subclinical Incubation period ~ 3 weeks
63
Diagnosis Cell culture (takes 3-7 days) of vigorous swab of mucous membranes: use dacron or rayon swabs-submit in viral/chlamydial transport medium at 4 C Endocervix preferred site (urethra from men) DFA, gene probes, EIA
64
Clinical Disease Ophthalmia neonatorum ( inclusion conjunctivitis) acquired during passage through birth canal May develop pneumonitis Adults may get from autoinoculation from genital tract (trachoma)
65
Clinical Disease Males: 75% symptomatic urethritis, dysuria & pyuria, proctitis Females: 80% asymptomatic, some cervicitis, urethritis, salpingitis 40% of untreated females pelvic inflammatory disease (PID) Leads to tubal pregnancy, infertility Tubal pregnancy = leading cause of 1st trimester pregnancy-related deaths Females with chlamydia 3-5 fold risk of HIV
66
More Clinical Disease Reiter’s Syndrome: conjunctivitis, polyarthritis & genital infection most HLA-B27 + Lymphogranuloma venereum (L biovars): painful “buboes” = enlarged draining lymph nodes, may develop elephantiasis, ulcers or fistulas
67
Treatment Tetracycline or erythromycin No vaccines Penicillin ineffective Important since gonococcus co-infections may occur
68
PAP smear with chlamydial inclusion body
69
Trachoma: conjunctivitis from Chlamydia infection
70
Lymphogranuloma venereum: unilateral inguinal swelling
71
Necrotic lymph node of lymphogranuloma venereum
72
Triple zone of stellate abscess of lymphogranuloma venereum
73
Gonorrhea Neisseria gonorrhoeae Gram negative diplococci, gonococcus (GC) Frequently found intracellularly in PMNs Is oxidase positive: cytochrome C oxidase phenylenediamine black color
74
Gonorrhea Have pili attach to mucosal surfaces Pili show antigenic variation Protein II (opacity) clumping (aggregation) IgA proteases may degrade host IgA LPS May bind to sperm, rbcs, non-ciliated fallopian tube epithelium May invade dissemination
75
Epidemiology Incidence declining May be under diagnosed in females Still 500-700,000 cases per year in US Highly contagious: 50% transmission rate Chlamydia coexists in 45-50% of pts with gonorrhea
76
Gonorrhea — Rates: United States, 1970–2002
77
Gonorrhea — Rates by state: United States and outlying areas, 2002
78
Gonorrhea — Rates by race and ethnicity: United States, 1981–2002
79
Clinical Disease Incubation 2-7 days Males: urethritis, dysuria, pyuria (copius urethral discharge), epididymitis, proctitis, orchitis Conjunctivitis in newborns exposed to infected secretions in birth canal 50% of women asymptomatic Cervicitis, adenitis, proctitis, salpingitis, ovaritis, PID in 15%
80
More Clinical Disease Disseminated : more common during pregnancy (endocytosis of GC) seen in 0.3 - 3% of pts Dermatitis papules & pustules with hemorrhagic component Arthritis knees, elbows, tenosynovitis Rarely endocarditis, meningitis, Waterhouse-Friderichsen syndrome (hemorrhagic destruction of adrenal gland)
81
Diagnosis Culture on Thayer-Martin media in high CO 2 (oxidase + colonies) Gram negative cocci in pairs GC don’t ferment maltose, meningococci do Gene Probe
82
Treatment Penicillin resistance 15-19% Tetracycline resistance 17-23% Emerging fluoroquinolone resistance No resistance to 3rd generation cephalosporins Disseminated: 7-14 days after infection
83
Gonorrhea: purulent discharge from urethral meatus
84
PMNs containing diplococci
85
Pustule of disseminated gonorrhea
86
Syphilis Treponema pallidum Spirochete with axial filament (motile) Gram negative but too thin to see by light microscopy (0.2 by 6-15 m) Man only natural host (grows in rabbit skin/testes) Never cultured in vitro Transmission by direct sexual contact
87
Syphilis Periods of latency and clinical disease Infection may last decades Since arrival of penicillin in 1940’s, rate has Produces no known toxins Pathology likely from humoral and cellular immune responses Syphilis risk of HIV (HIV risk of neurosyphilis)
88
Primary and secondary syphilis — Rates: United States, 1970–2002 and the Healthy People 2010 objective
89
Congenital syphilis — Rates for infants <1 year of age: United States, 1981–2002 and the Healthy People 2010 objective
90
Primary and secondary syphilis — Age- and sex-specific rates: United States, 2002
91
Clinical Disease “Great Imposter” Three stages: each involve lesser numbers with more severe CS x 1 syphilis chancre (hard, clean, painless, shallow ulcer) occurs ~ 3weeks after exposure Chancre: male 70% on penis or scrotum, female 50% on vulva or cervix, rest lips, oral cavity, finger, base is teeming with treponema
92
Clinical Disease Chancre resolves in 3-8 weeks Rx May have fever, lymphadenopathy 2 stage 2-10 weeks after 1 2 dissemination of spirochetes: diffuse macular rash including soles & palms, lymphadenopathy, erosions on mucous membranes, condyloma lata
93
Clinical Disease 3 stage latency may last decades Three categories of tertiary syphilis: 1.Cardiovascular aortitis, aortic aneurysm, aortic insufficiency (80% of mortality) 2.Neurosyphilis general paresis, meningovasculitis, tabes dorsalis (loss of posterior columns), psychiatric disease 3.Benign tertiary syphilis gummas = necrotizing granulomas skin, bones, subQ
94
Syphilitic chancre
95
Chancre: base contains treponema that can be visualized by dark field microscopy
96
Spirochetes
97
Maculopapular rash of secondary syphilis
98
Rash involves palms & soles
99
Condyloma lata of secondary syphilis Trepenomes are not readily found within lesions
100
Perivascular plasma cells are characteristic of syphilis
101
Obliterative endarteritis with plasma cell infiltrate
102
Gumma: rubbery focus of necrosis
103
Destructive gummas
105
Saddle nose
106
Opened syphilitic aortic aneurysm with adherent thrombus
107
CT scan of aortic aneurysm
108
Charcot joint
109
Saber shin
110
Congenital Syphilis Treponemes cross placenta after 5th month of gestation (more common if early syphilis) Causes stillbirth, spontaneous abortion (50% mortality), early or late congenital syphilis Early congenital: desquamating skin lesions,vesicles on mucous membranes, osteochondritis, pulmonary fibrosis, hepatosplenomegaly Late congenital: interstitial keratitis, gummas, saddle nose, saber shin (> 2 yrs), Charcot joints Classic triad: interstitial keratitis, notched incisors, eighth-nerve deafness
112
Hutchinson (notched) incisors
113
Hepatic fibrosis from congenital syphilis
114
Periostitis
115
Pathology Treponemes adhere to endothelium obliterative endarteritis Two major types of lesions: 1.perivascular plasma cells ( also lymphocytes, macrophages) 2.Gummas necrotizing granulomas 2 to delayed type hypersensitivity
116
Diagnosis Screening serology via non-treponemal tests: 1.VDRL (Venereal Disease Research Laboratory) 2.RPR (Rapid Plasma Reagin) These test for anti-cardiolipin antibodies (are in syphilis & many other diseases, ie Lupus) Are sensitive but non-specific
117
Diagnosis If chancre present dark field microscopy of material from base of lesion May be seen in silver stains or DFA staining of condylomas and skin lesions (less reliable) Confirmatory Tests for 2 & 3 syphilis : more specific and expensive 1.FTA-ABS most widely used, remains + after Rx (TOC) 2.Microhemagglutination-TP also used
118
Treatment Penicillin - no known resistance Single dose for active, multiple doses for latent May see Jarisch-Herxheimer reaction following Rx of 2 or 3 syphilis (hypersensitivity) Like other STIs condoms may not entirely prevent
119
Chancroid Haemophilus ducreyi Gram negative rod Now uncommon in US, common in Africa & SE Asia Causes soft chancre: painful genital ulcer Can be confused with syphilis, herpes, LGV
120
Chancroid Male:female ratio 9:1 Predisposes to HIV Characterized by single or multiple ulcers and inguinal adenopathy Grows on chocolate agar gram negative coccobacilli Presumably make cytotoxin and endotoxin
121
Rx and Prevention Some resistance to ampicillin and penicillin Condoms may prevent
122
Vaginitis Yeast vaginitis 80-90% Candida albicans Are NL flora overgrowth (birth control pills, antibiotics, diabetes) May be sexually transmitted (usually not) Dx: KOH wet mount for yeast, pseudohyphae & hyphae Dysuria, creamy discharge Rx: nystatin, imidazoles
123
Bacterial Vaginitis Gardnerella vaginalis Gram negative anaerobe NL flora Mild signs/increased odor (fishy) Dx: clue cells-epithelial cells covered with bacteria Rx: alter microenvironment
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.